Physiology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Physiology 20: 260-270, 2005; doi:10.1152/physiol.00012.2005
1548-9213/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rose, A. J.
Right arrow Articles by Richter, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rose, A. J.
Right arrow Articles by Richter, E. A.
Physiology, Vol. 20, No. 4, 260-270, August 2005
© 2005 Int. Union Physiol. Sci./Am. Physiol. Soc.

REVIEW

Skeletal Muscle Glucose Uptake During Exercise: How is it Regulated?

Adam J. Rose and Erik A. Richter

Department of Human Physiology, Institute of Exercise and Sport Sciences, Copenhagen Muscle Research Centre, University of Copenhagen, Copenhagen, Denmark

erichter{at}ifi.ku.dk


   Abstract
 
The increase in skeletal muscle glucose uptake during exercise results from a coordinated increase in rates of glucose delivery (higher capillary perfusion), surface membrane glucose transport, and intracellular substrate flux through glycolysis. The mechanism behind the movement of GLUT4 to surface membranes and the subsequent increase in transport by muscle contractions is largely unresolved, but it is likely to occur through intracellular signaling involving Ca2+-calmodulin-dependent protein kinase, 5'-AMP-activated protein kinase, and possibly protein kinase C.


   Introduction
Top
 Introduction
Regulation of Skeletal Muscle...
 Regulation of Skeletal Muscle...
 Summary and Perspectives
 References
 
During dynamic exercise, the turnover of ATP in skeletal muscle increases greatly and is fuelled by the catabolism of carbohydrates (intramuscular glycogen, blood glucose) and fatty acids (intramuscular triglycerides, blood lipids). During exercise in the postabsorptive state, the contribution of blood glucose to ATP resynthesis is initially relatively minor, but as exercise continues and muscle glycogen stores are depleted, the contribution of blood glucose becomes more substantial, reaching ~35% of leg oxidative metabolism and close to 100% of muscle carbohydrate metabolism (1, 2, 28, 104, 139). Probably the most influential factor for the magnitude of increase in muscle glucose uptake during exercise in the postabsorptive state is exercise intensity, with skeletal muscle glucose uptake being greater at higher exercise intensities (FIGURE 1Go; Refs. 104 and 131). This is probably due to a combination of greater fiber recruitment (45) as well as higher metabolic stress on active muscle fibers (59, 60) at higher exercise intensities. During exercise, the major metabolic fate of blood glucose after entry into skeletal muscle cells is glycolysis (139, 157) and subsequent oxidation (61, 157).



View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 1. Leg glucose uptake at rest and during cycle ergometer leg exercise at different power outputs
Skeletal muscle glucose uptake increases substantially during dynamic exercise. The increase is dependent mainly on exercise intensity but also on exercise duration. Adapted from Wahren et al. (131).

 
Regular exercise can improve glycemic control (11, 12). This may be due, in part, to the acute effects of exercise on glucose metabolism as well as training-induced adaptations. In individuals with type II diabetes, a single bout of exercise can reduce blood glucose concentrations (83) mainly because the exercise-induced increase in skeletal muscle glucose uptake is intact (79) even when insulin action is impaired. Thus the molecular mechanism resulting in increased muscle glucose transport during exercise is recognized as a clinically relevant alternative pathway to increase glucose disposal in skeletal muscle in states of insulin resistance.


   Regulation of Skeletal Muscle Glucose Uptake During Exercise
Top
 Introduction
 Regulation of Skeletal Muscle...
Regulation of Skeletal Muscle...
 Summary and Perspectives
 References
 
There are three sites of regulation of skeletal muscle glucose uptake in vivo: glucose delivery to the skeletal muscle cells, surface membrane permeability to glucose (i.e., glucose transport), and flux through intracellular metabolism (FIGURE 2Go). Whether one or a combination of these factors is rate limiting to tissue uptake has proven difficult to discern. Glucose delivery or supply to a tissue vascular bed is usually expressed as the product of blood flow and blood glucose concentration. Because muscle blood flow can increase up to 20-fold during intense exercise (4), the increase in muscle perfusion is of large quantitative importance for the increase in glucose supply (97). In vitro studies of glucose uptake during electrical stimulation of perfused rat hindlimb muscles indicate that perfusion is important for the rate of glucose uptake during contractions (52), but whether perfusion limits glucose uptake under normal exercise conditions is questionable. If flow were to be limiting during exercise, a decrease in the interstitial glucose concentration would be expected. However, this is not the case, as skeletal muscle interstitial glucose concentration is actually higher when comparing exercising and rested limbs (76). On the other hand, increasing glucose supply to the working muscle by raising glucose concentrations during contractions in vitro (85, 91) or during exercise in vivo (97, 157) increases skeletal muscle glucose uptake during exercise even when insulin levels are prevented from rising (FIGURE 3Go). Conversely, during prolonged exercise when blood glucose concentration decreases, leg glucose uptake decreases as well (1). It is noteworthy that within the physiological range of glucose concentrations the relationship between plasma glucose concentration and glucose uptake in muscle during exercise is almost linear, indicating that changes in plasma glucose concentrations during exercise translate almost proportionally to changes in glucose uptake by muscle (FIGURE 3Go). Thus, whereas the increase in muscle blood flow seems well matched to the metabolic demands of muscle (4) and does not pose an obvious limitation to glucose uptake in healthy individuals, the blood glucose concentration is an important limiting factor for glucose uptake during exercise.



View larger version (29K):
[in this window]
[in a new window]
  		FIGURE 2. Rate-limiting steps of glucose uptake by skeletal muscle
Glucose diffuses from the capillary to the muscle surface membranes, is transported across these membranes by facilitated diffusion, and is irreversibly phosphorylated in the myocyte, provided that there is a glucose concentration gradient. Each of these steps is tightly coupled and may be limiting during exercise. Shown below each step are the main mechanisms of regulation.

 


View larger version (18K):
[in this window]
[in a new window]
  		FIGURE 3. Glucose uptake across the thigh during moderate-intensity, dynamic knee-extensor exercise performed by humans
Glucose uptake was measured after 30 min of exercise at each plasma glucose concentration. Plasma insulin concentration was clamped at basal levels by infusion of somatostatin and replacement insulin. Values are means ± SE; n = 4. Km was calculated to be 10.5 mM and Vmax to be 1.67 mmol•kg–1•min–1. Broken lines illustrate that if plasma glucose concentration increases from 4 to 8 mM during exercise, this would result in almost a doubling of the rate of leg glucose uptake. It should be noted that, depending on exercise intensity, an increase in plasma glucose concentration to 8 mM might increase plasma insulin concentrations under normal conditions when plasma insulin is not clamped, and it would perhaps increase leg glucose uptake even further (30). Modified from Richter (97).

 
Skeletal muscle expresses multiple isoforms of glucose transporters (93). During exercise the most important of these is GLUT4, because systemic (110) and muscle-specific (158) GLUT4 knockout abolishes contraction-stimulated glucose uptake, at least when studied in vitro. Several studies suggest that glucose transport is rate limiting for glucose uptake into muscle during exercise. Derave et al. (32) provided evidence that membrane transport is a limiting step for glucose uptake during exercise in a study in which the perfused rat hindlimb preparation was used and the magnitude of glucose uptake during contractions was altered by differing initial muscle glycogen concentrations manipulated by prior exercise and diet. It was shown that there was a strong positive correlation between sarcolemmal GLUT4 content and glucose uptake, at least in muscles that contained primarily fast-twitch fibers (32). Studies of humans also suggest that glucose transport may be rate limiting for glucose uptake in skeletal muscle during moderate-intensity exercise, because intramuscular glucose does not accumulate except perhaps in the first few minutes of exercise (64, 99), which would be expected if phosphorylation of glucose was limiting. However, during intense exercise when glycogenolysis is very rapid and formation of glucose-6-phosphate (G6P) is pronounced, the ensuing inhibition of hexokinase (HK) may make glucose phosphorylation, rather than transport, limiting (63, 69).

Skeletal muscle glucose transport follows Michaelis-Menten kinetics, and most studies show that exercise increases the Vmax of glucose transport without affecting Km (66, 122, 157), suggesting that the number but not affinity for glucose of individual transporters is higher with exercise. Even so, a study in perfused rat hindlimb demonstrated both a contraction-induced increase in Vmax and a decrease in Km for glucose transport (91) that was subsequently supported by data obtained in isolated plasma membrane vesicles from rat muscle (90). These data indicate that the activity of each glucose transporter may increase with contractions. Similar to the action of insulin, it has been demonstrated that muscle contractions increase the sarcolemmal and transverse-tubular content of GLUT4 (FIGURE 4Go) using several different methods and models (34, 35, 36, 46, 70, 74, 75, 92, 108, 109, 126), thereby enhancing the facilitated diffusion of glucose into the muscle cells. The increased GLUT4 abundance in the transverse tubules is hypothesized to account for a substantial proportion of the overall increase in skeletal muscle glucose transport, allowing delivery of glucose deep into the myoplasm (33).



View larger version (63K):
[in this window]
[in a new window]
  		FIGURE 4. Putative regulation of glucose uptake and GLUT4 "translocation" in skeletal muscle during exercise/contractions
The higher glucose transport with exercise mainly occurs due to higher amounts of glucose transport protein GLUT4 in surface membranes, more specifically the sarcolemma and transverse tubules (T-tubules). The mechanisms behind this are unclear but may involve several kinases that sense and transduce signals relating to changes in the intracellular environment during contractions (i.e., higher Ca2+, AMP concentrations) to other undefined proteins involved in GLUT4 movement and insertion into membranes. Question marks refer to unidentified signaling and structural molecules that are involved in this process. G6P, glucose-6-phosphate; AS160, Akt substrate of 160 kDa; AMPK, 5'-AMP-activated protein kinase; CaM, calmodulin; CaMK, Ca2+-CaM dependent protein kinase; PKB, protein kinase B (also known as Akt); PKC, protein kinase C; NOS, nitric oxide synthase.

 
Recent studies using genetic manipulation to alter the expression of proteins involved in glucose transport and metabolism have shed some light on the possible limiting steps in glucose uptake during exercise. Wasserman and colleagues have demonstrated that neither GLUT4 overexpression nor partial knockout alter exercise-stimulated increases in skeletal muscle glucose uptake in vivo (40, 42), indicating that the increase in surface membrane GLUT4 is a permissive step in glucose uptake under normal conditions or that only a percentage of the total GLUT4 pool is required for the increase in surface membrane permeability with exercise. Further work by Wasserman and colleagues using mice with skeletal muscle HKII overexpression or partial knockout implicate an important role for HKII in the regulation of glucose uptake by working murine muscle in vivo (40, 41, 42, 48). However, when mice with a partial knockout of skeletal muscle HKII were exercised, there was a limitation to glucose uptake only in the oxidative skeletal muscles during exercise and no discernable effect in muscles of a mixed fiber type (41). Given that human vastus lateralis (the muscle typically sampled for biochemical measures, representative of leg glucose uptake) is of a heterogeneous fiber population (116), it is difficult to extend these findings to humans. Furthermore, in individuals with type II diabetes who have lower maximal HKII activity (88) and hence expression, skeletal muscle glucose uptake is normal (79), perhaps because perfusion (79, 135) and GLUT4 translocation (65) during exercise are not impaired. Lastly, there is very little direct evidence that skeletal muscle HK activity is altered by acute contractile activity or exercise in mammals (133), and there are no studies that have directly examined the relationship between possible acute changes in HK activity and glucose uptake with exercise. However, the apparent lack of fine control of HK activity during exercise may very well be the reason that HK can limit glucose uptake in some circumstances. Overall, the role of HK in regulation of glucose uptake during exercise in humans is ambiguous and probably only limiting to glucose uptake during intense exercise when G6P accumulates and inhibits HK activity.

In summary, glucose supply, transport, and phosphorylation are important regulatory steps of skeletal muscle glucose uptake during exercise (FIGURE 2Go). Whether one or a combination of these factors is rate limiting to glucose uptake in the intact mammal has proven difficult to discern, because all steps are likely to be closely coupled to the metabolic state of the muscle fiber as well as the percentage of fibers recruited. It may be that oxidative muscles rely more on glucose supply (perfusion) and phosphorylation by HK (41, 77), with glycolytic muscles probably relying more on glucose transport (32, 108). From a hypothetical perspective, it is also likely that even within the same muscle fiber the limiting step for glucose uptake varies depending on a variety of factors, including the intensity and duration of exercise and muscle glycogen and interstitial glucose concentrations.

Given that there is little known about the regulation of HK activity by acute exercise (133) and that there are several recent reviews on the regulation and putative molecular events leading to hyperemia (25) and greater microvascular flow (95) and thus substrate supply in skeletal muscle with exercise, the following section focuses on the regulation of membrane glucose transport by exercise/contraction.


   Regulation of Skeletal Muscle Glucose Transport by Exercise/Contraction
Top
 Introduction
 Regulation of Skeletal Muscle...
 Regulation of Skeletal Muscle...
Summary and Perspectives
 References
 
The molecular events involved in stimulating GLUT4 movement within muscle cells are complex (18, 134). There is evidence that there are distinct contraction and insulin-responsive GLUT4 vesicle "pools" in skeletal muscle (26, 35, 74, 92) and that the molecular signals that trigger increased glucose transport and surface membrane GLUT4 are different when comparing insulin and contraction stimulation (58, 73, 75, 151). Indeed, insulin, but not contractions, results in changes in distribution of the rab4 protein (118) and contractions, but not insulin, alter the distribution of the transferrin receptor (74). Even so, there are likely to be similarities between the two stimuli, as both exercise and insulin probably recruit GLUT4 vesicles that contain vesicle-associated membrane protein-2 (70, 94) and insulin-responsive aminopeptidase (26) as well as stimulate higher sarcolemmal content of GTP-binding proteins (36). Although it is not known whether the higher surface membrane GLUT4 with contraction results from a slower endocytosis or faster exocytosis of GLUT4 vesicles in intact mammalian skeletal muscle, insights from work with cultured cardiomyocytes suggest the latter (152).

Signaling mechanisms involved in contraction-stimulated glucose transport
Although the signaling mechanisms that are involved in insulin-stimulated glucose transport are still partly unresolved (134), even less is known about the molecular mechanisms responsible for the increase in glucose transport and GLUT4 translocation during muscle contraction (FIGURE 4Go). It is generally accepted that the underlying signals occur independently of humoral factors and arise from local factors within the contracting skeletal muscle (97). Indeed, it has been demonstrated numerous times that contraction of skeletal muscle ex vivo results in higher glucose transport compared with basal conditions. Furthermore, the use of these reductionist models such as the perfused hindlimb and incubated muscle techniques allow greater insight into the regulation of glucose transport, because glucose supply can be precisely controlled (10, 142).

Role of Ca2+ signaling
The transient "spikes" in intracellular Ca2+ that occur with muscle contractions have for more than 30 years been hypothesized to be involved in contraction-stimulated glucose transport (56). Since the intracellular Ca2+ level is related to the activity of the motor nerves, signaling directly influenced by Ca2+ can be considered as feedforward regulation. The original studies were performed in frog sartorius muscle incubated with caffeine, which releases Ca2+ from the sarcoplasmic reticulum. In rat epitrochlearis muscle, raising intracellular Ca2+ by treatment with caffeine in vitro also increases glucose transport (125, 154). In contrast, other in vitro studies have shown no effect of Ca2+ ionophores on basal skeletal muscle glucose transport, with an inhibition of insulin-stimulated glucose transport (68, 72). The discrepancies between these findings are difficult to explain but may relate to the magnitude and duration of the increase in cytosolic Ca2+ (72). Importantly, at the concentrations used, none of these agents alter muscle force development or the concentration of high-energy phosphate compounds (72, 154), both of which are believed to be important factors in regulating skeletal muscle glucose transport (see below).

Other studies have sought to resolve the role of Ca2+ by examining Ca2+-activated enzymes. Conventional isoforms of protein kinase C (PKC) are activated in response to increases in cellular Ca2+ and diacylglycerol (DAG) (87). In rats, skeletal muscle PKC activity, as determined by translocation of PKC to a membrane fraction, is higher with exercise/contractions (24, 98), but this finding could not be replicated in humans (106). Furthermore, chronic downregulation (23) as well as chemical inhibition (58, 143) of conventional and novel PKC isoforms results in reduced contraction-stimulated glucose transport. However, the effect of inhibition of DAG-sensitive PKC by the microbial agent calphostin C was much more pronounced in fast-twitch than in slow-twitch muscles (143), a finding that is not surprising given that artificial activation of DAG-sensitive PKCs by phorbol esters results in increased glucose transport in rat fast-twitch but not slow-twitch muscles (150). Thus, although there are some studies that suggest that the conventional and novel PKC isoforms may be involved in contraction-induced glucose uptake, it is clear that more definitive studies are required to resolve the role of these enzymes in this process.

Another ubiquitously expressed Ca2+-sensing protein is calmodulin (CaM). Studies using CaM inhibitors show reductions in contraction-stimulated glucose transport, perhaps because CaM inhibition leads to reduced tension development (58), a result likely due to the role of CaM in many signaling processes in skeletal muscle, including excitation-contraction coupling (124, 130). However, specific inhibition by KN62/93 of the multifunctional kinases that are activated by Ca2+-bound CaM (i.e., CaMKI, -II, -IV) (29, 53) leads to partial reduction in contraction-stimulated glucose transport in epitroclearis (151) and complete abolition in soleus (149) muscles of rats in vitro. This inhibitor also reduces contraction-stimulated glucose transport in murine soleus and extensor digitorum longus muscles, without affecting tension development in this model (T. E. Jensen, A. J. Rose, J. F. P. Wojtaszewski, and E. A. Richter, unpublished observations). Importantly, CaMKII activity is increased in contracting skeletal muscle of humans (105) and rodents (A. J. Rose, T. E. Jensen, and E. A. Richter, unpublished observations) during exercise/contraction, and KN62/93 impairs the activation of CaMKII by contractions in vitro (151). However, although CaMKII is the likely target of KN62/93, the involvement of the other multifunctional CaMK isoforms such as CaMKI cannot be ruled out. Indeed, CaMKI is expressed in skeletal muscle (3), whereas CaMKIV is not (3, 105). However, the observation that insulin stimulation of glucose transport is also partially inhibited by KN62 (16, 148) suggests that insulin action is partially dependent on CaMK but also raises the possibility that KN62 inhibits glucose transport nonspecifically. Clearly, further study is required to clarify this issue.

Nitric oxide synthase (NOS) is also activated by Ca2+-bound CaM (12). NOS is expressed in skeletal muscle cells, and there is evidence from rodent studies that NOS activity (101) and nitric oxide production (5) are increased during exercise. There is equivocal evidence regarding the involvement of NOS in contraction-stimulated glucose transport in skeletal muscle of rats, with some studies indicating no effect (37, 54, 107) and other studies showing a reduction (6, 102, 121) in muscles treated with NOS inhibitors. Inhibition of NOS leads to reduced glucose uptake without affecting total blood flow across the working limb of humans in vivo (13, 67). This does not rule out an effect of NOS inhibition on glucose supply, as the inhibitor used in these studies probably affects endothelial NOS, and nitric oxide is believed to be involved in increasing nutritive microvascular flow with exercise/contraction (95). As changes in nutritive flow can occur in the absence of changes in total flow (129), the effect of NOS inhibition on glucose uptake in humans might be explained by regulation of nutritive flow rather than membrane transport, although this remains to be established.

Signaling related to metabolic status of muscle
Early studies observed an inverse relationship between the phosphocreatine concentration and glucose uptake by contracting muscle (63, 132), suggesting a role for signals that sense metabolic stress in contraction-stimulated glucose transport. This may be regarded as feedback regulation of glucose transport. In an attempt to address this issue, Ihlemann et al. (59, 60) employed a model in which the force development was manipulated while the stimulation frequency and muscle fiber recruitment were kept constant to alter metabolic stress, presumably without disturbing Ca2+ signaling. There was a positive relationship between force development and skeletal muscle glucose uptake in both slow-twitch and fast-twitch muscles (59, 60). Thus an energy-sensing signaling system is likely to be involved in stimulating glucose transport with contractions. Indeed, 5'-AMP-activated protein kinase (AMPK) may be the enzyme that fulfils this role. AMPK is a multifunctional serine/threonine protein kinase that acts as an important sensor of cellular energy charge, as reflected by the ratios of AMP/ATP and creatine/phosphocreatine (49). AMPK activity is higher in skeletal muscle during exercise/contraction (21, 31, 43, 62, 83, 128, 145, 146). Furthermore, the magnitude of activation of AMPK is dependent on exercise intensity (22, 145), which may relate to the higher metabolic stress of recruited fibers, particularly in fast-twitch muscles (31, 60). Because activation of AMPK in resting muscle by the drug 5'-aminoimidazole-4-carboxyamide-ribonucleoside (AICAR) increases glucose transport/uptake (9, 50, 80), it would seem logical to ascribe a role for AMPK in contraction-stimulated glucose transport. However, experiments with genetically manipulated mice with knockout of catalytic (62) or regulatory (7) AMPK subunits or overexpression of functionally inactive AMPK (44, 82) in skeletal muscles have yielded conflicting results as to whether or not AMPK is involved in contraction-stimulated glucose transport. The studies that have reduced AMPK activity only partially (7, 44, 62) have failed to demonstrate an effect of manipulation of AMPK on contraction-stimulated glucose transport despite the evidence that the knockout completely abolished the effect of AICAR on glucose transport in resting muscle (7, 62). On the other hand, in the study by Mu et al. (82) in which the muscles apparently were without any AMPK enzymatic activity, a 30–40% reduction in contraction-stimulated glucose transport in fast- and slow-twitch muscles was observed. However, later studies on these mice revealed that there were differences in force development during repeated contractions (81), a factor that could explain the lower contraction-stimulated glucose transport (59, 60). In addition, using the perfused rat hindlimb, a dissociation between AMPK activity and glucose uptake was observed in slow-twitch but not in fast-twitch muscle, pointing to a differing role of AMPK in different muscle fiber types (31). It was demonstrated (31) that AMPK activity during contractions of fast-twitch muscle was reciprocally related to muscle glycogen content, a finding that has been replicated in humans during exercise (103, 145). Thus, although AMPK is an attractive candidate for signaling in contraction-stimulated muscle glucose uptake, the available evidence pro and con at this time does not lead to a clear conclusion regarding its role. At the very least, there does not appear to be a simple "dose-response" relationship between AMPK activity and glucose transport during contractions.

Role of insulin-signaling intermediates
Insulin and muscle contractions both increase muscle glucose transport, and an obvious question to propose is whether proteins involved in signaling to insulin-stimulated glucose transport are involved in contraction signaling to glucose transport. It has been shown that exercise or muscle contraction does not increase tyrosine phosphorylation of the insulin receptor or insulin receptor substrate proteins (47, 57). With respect to phosphatidylinositol 3-kinase (PI3K), studies using incubated muscle (73, 75, 153) show that inhibition of PI3K does not influence contraction-stimulated glucose transport, a result not surprising given that skeletal muscle PI3K activity is not higher with exercise/contraction (47, 120, 136, 140, 141, 156), at least for those isoforms examined. However, in the perfused rat hindlimb, the PI3K inhibitor wortmannin was shown to inhibit contraction-induced muscle glucose uptake (140, 142). The discrepancies between ex vivo (73, 75, 153) and perfused hindlimb (140, 142) studies examining the effect of wortmannin on contraction-stimulated glucose transport may possibly be explained by factors not present in the incubated muscle preparation, such as nerve-derived agents. Indeed, stimulation of neuregulin receptors increases skeletal muscle glucose transport in a PI3K-dependent wortmannin-sensitive manner (19, 123), and given that neuregulin receptor tyrosine phosphorylation is higher with nerve-induced contractions (71), this factor may explain differences in wortmannin sensitivity on contraction-stimulated glucose transport between the two models used.

Some (111, 112, 114, 126, 127, 136) but not all (15, 78, 138, 147) studies demonstrate that skeletal muscle protein kinase B (PKB; also known as Akt) activity/phosphorylation is higher during exercise/contractions. It was recently shown that the Ser/Thr phosphorylation of the PKB/Akt substrate of 160 kDa (AS160) that is involved in GLUT4 translocation and perhaps glucose transport with insulin in adipocytes (117, 155) is increased by contractions in rodent skeletal muscle (17). However, both PKB and AS160 are unlikely to be involved in contraction-stimulated glucose uptake, as their activation/phosphorylation with contraction is inhibitable by the drug wortmannin (17, 114), whereas typically contraction-stimulated glucose transport in incubated muscle is not (see above). Indeed, a preliminary report has demonstrated no effect of PKB-ß knockout on contraction-stimulated glucose uptake in soleus muscle of mice (115).

Atypical PKC (aPKC) isoforms are activated by phosphorylation and lipid (i.e., phosphatidylinositol trisphosphate, phosphatidic acid) binding (38), and studies have consistently shown that aPKC activity is higher in contracting muscle during exercise (8, 20, 86, 89, 100, 106), although the mechanism for activation remains unclear (106). Given that aPKC, like PKB, is linked to insulin-stimulated glucose transport (38, 137) the increase in aPKC activity during exercise may indicate that aPKC also has a role in contraction-induced glucose uptake as well; however, there are currently no studies to directly support this notion.

Mitogen-activated protein kinase isoforms (i.e., ERK, p38, JNK) are activated by insulin and exercise/contraction (113). A link between the MAP kinases ERK and aPKC has been suggested in AICAR-stimulated glucose transport (20), and in a human study the exercise-induced increase in aPKC activity correlated with the increase in ERK activity (86). Contraction-stimulated glucose transport is partially inhibited by the drug SB203580 (119), which inhibits the {alpha}- and ß-isoforms of p38 MAPK (29). However, as this drug may also directly affect glucose transport by binding and inhibition of GLUT4 activity, as inferred from experiments using measurement of glucose transport during insulin stimulation in adipocytes (96), the effect of this SB203580 on glucose transport may not be entirely attributable to inhibition of p38. Furthermore, Ho et al. (55) have recently demonstrated that p38{gamma}, the major p38 isoform in skeletal muscle, is unlikely to be involved in contraction-stimulated glucose transport. Lastly, blockade of the activation of ERK isoforms does not result in inhibition of contraction-stimulated glucose transport (51, 144).


   Summary and Perspectives
Top
 Introduction
 Regulation of Skeletal Muscle...
 Regulation of Skeletal Muscle...
 Summary and Perspectives
References
 
The increase in skeletal muscle glucose uptake during exercise probably results from a coordinated increase in rates of glucose delivery (higher capillary perfusion), surface membrane transport, and intracellular substrate flux through glycolysis. Despite considerable research, relatively little is known about how exercise/contraction regulates skeletal muscle glucose transport (FIGURE 4Go). Although there is evidence linking activation of CaMK isoforms and AMPK in this process, the evidence is presently not clear cut. The signaling through CaMK isoforms is probably related to the motor nerve activity and could be regarded as a feedforward level of regulation. On the other hand, AMPK is activated when the energy status of the muscle is decreased, and hence its activation can be regarded as a feedback level of regulation. PKC, NOS, or PKB/Akt isoforms may also be involved in regulation of contraction-induced glucose transport, but this is presently unresolved. Furthermore, there are very few defined substrates that may act downstream of these activated kinases. However, it has been hypothesized that, because insulin and contraction signaling both ultimately result in GLUT4 translocation, there may be convergent signaling intermediates (27). Indeed, aPKC activity is higher with insulin and exercise/contraction stimulation, and this signaling intermediate, as well as other yet-undefined participants, may represent the putative convergent steps toward signaling to glucose transport. Knowledge of these signaling mechanisms is important, as exercise can increase skeletal muscle glucose uptake and GLUT4 translocation normally in individuals with type II diabetes. Thus the exercise-stimulated molecular mechanism resulting in increased muscle glucose transport may be important as an alternative pathway to increase glucose disposal in skeletal muscle in states of insulin resistance. In fact, drugs such as metformin and rosiglitazone that can activate skeletal muscle AMPK (39, 84) are widely used to treat type II diabetes.


   Acknowledgments
 
We would like to thank Jørgen F. P. Wojtaszewski, Sebastian Beck Jørgensen, and Thomas E. Jensen for their careful and critical review of the manuscript before submission.

A. J. Rose is supported by an Integrated Project funded by the European Union (contract number LSHM-CT-2004-005272) and by a postdoctoral fellowship from the Carlsberg Foundation. The Copenhagen Muscle Research Centre, the Danish Medical Research Council, the Danish Natural Science Research Council, The Novo-Nordisk Research Foundation, and the Danish Diabetes Association are gratefully acknowledged for supporting cited studies by the authors.


   References
Top
 Introduction
 Regulation of Skeletal Muscle...
 Regulation of Skeletal Muscle...
 Summary and Perspectives
 References
 

  1. Ahlborg G, Felig P, Hagenfeldt L, Hendler R, and Wahren J. Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids. J Clin Invest 53: 1080–1090, 1974.[ISI][Medline]
  2. Ahlborg G and Felig P. Lactate and glucose exchange across the forearm, legs, and splanchnic bed during and after prolonged leg exercise. J Clin Invest 69: 45–54, 1982.[ISI][Medline]
  3. Akimoto T, Ribar TJ, Williams RS, and Yan Z. Skeletal muscle adaptation in response to voluntary running in Ca2+/calmodulin-dependent protein kinase IV-deficient mice. Am J Physiol Cell Physiol 287: C1311–C1319, 2004.[Abstract/Free Full Text]
  4. Andersen P and Saltin B. Maximal perfusion of skeletal muscle in man. J Physiol 366: 233–249, 1985.[Abstract/Free Full Text]
  5. Balon TW. Role of nitric oxide in contraction induced glucose transport. Adv Exp Med Biol 441: 87–95, 1998.[ISI][Medline]
  6. Balon TW and Nadler JL. Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol 82: 359–363, 1997.[Abstract/Free Full Text]
  7. Barnes BR, Marklund S, Steiler TL, Walter M, Hjalm G, Amarger V, Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M, Stapleton D, Zierath JR, and Andersson L. The 5'-AMP-activated protein kinase ?3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 279: 38441–38447, 2004.[Abstract/Free Full Text]
  8. Beeson M, Sajan MP, Dizon M, Grebenev D, Gomez-Daspet J, Miura A, Kanoh Y, Powe J, Bandyopadhyay G, Standaert ML, and Farese RV. Activation of protein kinase C-{zeta} by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. Diabetes 52: 1926–1934, 2003.[Abstract/Free Full Text]
  9. Bergeron R, Russell RR 3rd, Young LH, Ren JM, Marcucci M, Lee A, and Shulman GI. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol Endocrinol Metab 276: E938–E944, 1999.[Abstract/Free Full Text]
  10. Bonen A, Clark MG, and Henriksen EJ. Experimental approaches in muscle metabolism: hindlimb perfusion and isolated muscle incubations. Am J Physiol Endocrinol Metab 266: E1–E16, 1994.[Abstract/Free Full Text]
  11. Boule NG, Haddad E, Kenny GP, Wells GA, and Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286: 1218–1227, 2001.[Abstract/Free Full Text]
  12. Boule NG, Weisnagel SJ, Lakka TA, Tremblay A, Bergman RN, Rankinen T, Leon AS, Skinner JS, Wilmore JH, Rao DC, and Bouchard C. Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care 28: 108–114, 2005.[Abstract/Free Full Text]
  13. Bradley SJ, Kingwell BA, and McConell GK. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes 48: 1815–1821, 1999.[Abstract]
  14. Bredt DS and Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682–685, 1990.[Abstract/Free Full Text]
  15. Brozinick JT Jr and Birnbaum MJ. Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. J Biol Chem 273: 14679–14682, 1998.[Abstract/Free Full Text]
  16. Brozinick JT Jr, Reynolds TH, Dean D, Cartee G, and Cushman SW. 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62), an inhibitor of calcium-dependent calmodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle. Biochem J 339: 533–540, 1999.
  17. Bruss MD, Arias EB, Lienhard GE, and Cartee GD. Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 54: 41–50, 2005.[Abstract/Free Full Text]
  18. Bryant NJ, Govers R, and James DE. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3: 267–277, 2002.[CrossRef][ISI][Medline]
  19. Canto C, Suarez E, Lizcano JM, Grino E, Shepherd PR, Fryer LG, Carling D, Bertran J, Palacin M, Zorzano A, and Guma A. Neuregulin signaling on glucose transport in muscle cells. J Biol Chem 279: 12260–12268, 2004.[Abstract/Free Full Text]
  20. Chen HC, Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert M, Farese RV Jr, and Farese RV. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-ß-D-riboside (AICAR)-stimulated glucose transport. J Biol Chem 277: 23554–23562, 2002.[Abstract/Free Full Text]
  21. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, and Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202–E1206, 2000.[Abstract/Free Full Text]
  22. Chen ZP, Stephens TJ, Murthy S, Canny BJ, Hargreaves M, Witters LA, Kemp BE, and McConell GK. Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Diabetes 52: 2205–2212, 2003.[Abstract/Free Full Text]
  23. Cleland PJ, Abel KC, Rattigan S, and Clark MG. Long-term treatment of isolated rat soleus muscle with phorbol ester leads to loss of contraction-induced glucose transport. Biochem J 267: 659–663, 1990.[Medline]
  24. Cleland PJ, Appleby GJ, Rattigan S, and Clark MG. Exercise-induced translocation of protein kinase C and production of diacylglycerol and phosphatidic acid in rat skeletal muscle in vivo. Relationship to changes in glucose transport. J Biol Chem 264: 17704–17711, 1989.[Abstract/Free Full Text]
  25. Clifford PS and Hellsten Y. Vasodilatory mechanisms in contracting skeletal muscle. J Appl Physiol 97: 393–403, 2004.[Abstract/Free Full Text]
  26. Coderre L, Kandror KV, Vallega G, and Pilch PF. Identification and characterization of an exercise-sensitive pool of glucose transporters in skeletal muscle. J Biol Chem 270: 27584–27588, 1995.[Abstract/Free Full Text]
  27. Cortright RN and Dohm GL. Mechanisms by which insulin and muscle contraction stimulate glucose transport. Can J Appl Physiol 22: 519–530, 1997.[ISI][Medline]
  28. Coyle EF, Coggan AR, Hemmert MK, and Ivy JL. Muscle glycogen utilization during prolonged strenuous exercise when fed carbohydrate. J Appl Physiol 61: 165–172, 1986.[Abstract/Free Full Text]
  29. Davies SP, Reddy H, Caivano M, and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95–105, 2000.[CrossRef][ISI][Medline]
  30. DeFronzo RA, Ferrannini E, Sato Y, Felig P, and Wahren J. Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest 68: 1468–1474, 1981.[ISI][Medline]
  31. Derave W, Ai H, Ihlemann J, Witters LA, Kristiansen S, Richter EA, and Ploug T. Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes 49: 1281–1287, 2000.[Abstract]
  32. Derave W, Lund S, Holman GD, Wojtaszewski J, Pedersen O, and Richter EA. Contraction-stimulated muscle glucose transport and GLUT-4 surface content are dependent on glycogen content. Am J Physiol Endocrinol Metab 277: E1103–E1110, 1999.[Abstract/Free Full Text]
  33. Dohm GL and Dudek RW. Role of transverse tubules (T-tubules) in muscle glucose transport. Adv Exp Med Biol 441: 27–34, 1998.[ISI][Medline]
  34. Douen AG, Ramlal T, Klip A, Young DA, Cartee GD, and Holloszy JO. Exercise-induced increase in glucose transporters in plasma membranes of rat skeletal muscle. Endocrinology 124: 449–454, 1989.[Abstract]
  35. Douen AG, Ramlal T, Rastogi S, Bilan PJ, Cartee GD, Vranic M, Holloszy JO, and Klip A. Exercise induces recruitment of the "insulin-responsive glucose transporter." Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. J Biol Chem 265: 13427–13430, 1990.[Abstract/Free Full Text]
  36. Etgen GJ Jr, Memon AR, Thompson GA Jr, and Ivy JL. Insulin- and contraction-stimulated translocation of GTP-binding proteins and GLUT4 protein in skeletal muscle. J Biol Chem 268: 20164–20169, 1993.[Abstract/Free Full Text]
  37. Etgen GJ Jr, Fryburg DA, and Gibbs EM. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 46: 1915–1919, 1997.[Abstract]
  38. Farese RV. Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am J Physiol Endocrinol Metab 283: E1–E11, 2002.[Abstract/Free Full Text]
  39. Fryer LG, Parbu-Patel A, and Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277: 25226–25232, 2002.[Abstract/Free Full Text]
  40. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, and Wasserman DH. Distributed control of glucose uptake by working muscles of conscious mice: roles of transport and phosphorylation. Am J Physiol Endocrinol Metab 286: E77–E84, 2004.[Abstract/Free Full Text]
  41. Fueger PT, Heikkinen S, Bracy DP, Malabanan CM, Pencek RR, Laakso M, and Wasserman DH. Hexokinase II partial knockout impairs exercise-stimulated glucose uptake in oxidative muscles of mice. Am J Physiol Endocrinol Metab 285: E958–E963, 2003.[Abstract/Free Full Text]
  42. Fueger PT, Hess HS, Posey KA, Bracy DP, Pencek RR, Charron MJ, and Wasserman DH. Control of exercise-stimulated muscle glucose uptake by GLUT4 is dependent on glucose phosphorylation capacity in the conscious mouse. J Biol Chem 279: 50956–50961, 2004.[Abstract/Free Full Text]
  43. Fujii N, Hayashi T, Hirshman MF, Smith JT, Habinowski SA, Kaijser L, Mu J, Ljungqvist O, Birnbaum MJ, Witters LA, Thorell A, and Goodyear LJ. Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273: 1150–1155, 2000.[CrossRef][ISI][Medline]
  44. Fujii N, Hirshman MF, Kane EM, Ho RC, Witczak C, Hayashi Y, Peter LE, and Goodyear LJ. Inhibition of AMPK{alpha}2 activity does not alter contraction-induced glucose transport in mouse skeletal muscle (Abstract). Diabetes 52S: A62, 2004.
  45. Gollnick PD, Piehl K, and Saltin B. Selective glycogen depletion pattern in human muscle fibres after exercise of varying intensity and at varying pedalling rates. J Physiol 241: 45–57, 1974.[Abstract/Free Full Text]
  46. Goodyear LJ, Hirshman MF, King PA, Horton ED, Thompson CM, and Horton ES. Skeletal muscle plasma membrane glucose transport and glucose transporters after exercise. J Appl Physiol 68: 193–198, 1990.[Abstract/Free Full Text]
  47. Goodyear LJ, Giorgino F, Balon TW, Condorelli G, and Smith RJ. Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle. Am J Physiol Endocrinol Metab 268: E987–E995, 1995.[Abstract/Free Full Text]
  48. Halseth AE, Bracy DP, and Wasserman DH. Overexpression of hexokinase II increases insulin and exercise-stimulated muscle glucose uptake in vivo. Am J Physiol Endocrinol Metab 276: E70–E77, 1999.[Abstract/Free Full Text]
  49. Hardie DG, Carling D, and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67: 821–855, 1998.[CrossRef][ISI][Medline]
  50. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ. Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369–1373, 1998.[Abstract]
  51. Hayashi T, Hirshman MF, Dufresne SD, and Goodyear LJ. Skeletal muscle contractile activity in vitro stimulates mitogen-activated protein kinase signaling. Am J Physiol Cell Physiol 277: C701–C707, 1999.[Abstract/Free Full Text]
  52. Hespel P, Vergauwen L, Vandenberghe K, and Richter EA. Important role of insulin and flow in stimulating glucose uptake in contracting skeletal muscle. Diabetes 44: 210–215, 1995.[Abstract]
  53. Hidaka H and Yokokura H. Molecular and cellular pharmacology of a calcium/calmodulin-dependent protein kinase II (CaM kinase II) inhibitor, KN-62, and proposal of CaM kinase phosphorylation cascades. Adv Pharmacol 36: 193–219, 1996.
  54. Higaki Y, Hirshman MF, Fujii N, and Goodyear LJ. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 50: 241–247, 2001.[Abstract/Free Full Text]
  55. Ho RC, Alcazar O, Fujii N, Hirshman MF, and Goodyear LJ. p38? MAPK regulation of glucose transporter expression and glucose uptake in L6 myotubes and mouse skeletal muscle. Am J Physiol Regul Integr Comp Physiol 286: R342–R349, 2004.[Abstract/Free Full Text]
  56. Holloszy JO and Narahara HT. Enhanced permeability to sugar associated with muscle contraction. Studies of the role of Ca++. J Gen Physiol 50: 551–562, 1967.[Abstract/Free Full Text]
  57. Howlett KF, Sakamoto K, Hirshman MF, Aschenbach WG, Dow M, White MF, and Goodyear LJ. Insulin signaling after exercise in insulin receptor substrate-2-deficient mice. Diabetes 51: 479–483, 2002.[Abstract/Free Full Text]
  58. Ihlemann J, Galbo H, and Ploug T. Calphostin C is an inhibitor of contraction, but not insulin-stimulated glucose transport, in skeletal muscle. Acta Physiol Scand 167: 69–75, 1999.[CrossRef][ISI][Medline]
  59. Ihlemann J, Ploug T, Hellsten Y, and Galbo H. Effect of tension on contraction-induced glucose transport in rat skeletal muscle. Am J Physiol Endocrinol Metab 277: E208–E214, 1999.[Abstract/Free Full Text]
  60. Ihlemann J, Ploug T, and Galbo H. Effect of force development on contraction induced glucose transport in fast twitch rat muscle. Acta Physiol Scand 171: 439–444, 2001.[CrossRef][Medline]
  61. Jeukendrup AE, Raben A, Gijsen A, Stegen JH, Brouns F, Saris WH, and Wagenmakers AJ. Glucose kinetics during prolonged exercise in highly trained human subjects: effect of glucose ingestion. J Physiol 515: 579–589, 1999.[Abstract/Free Full Text]
  62. Jørgensen SB, Viollet B, Andreelli F, Frøsig C, Birk JB, Schjerling P, Vaulont S, Richter EA, and Wojtaszewski JF. Knockout of the {alpha}2 but not {alpha}1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-ß-4-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279: 1070–1079, 2004.[Abstract/Free Full Text]
  63. Katz A, Broberg S, Sahlin K, and Wahren J. Leg glucose uptake during maximal dynamic exercise in humans. Am J Physiol Endocrinol Metab 251: E65–E70, 1986.[Abstract/Free Full Text]
  64. Katz A, Sahlin K, and Broberg S. Regulation of glucose utilization in human skeletal muscle during moderate dynamic exercise. Am J Physiol Endocrinol Metab 260: E411–E415, 1991.[Abstract/Free Full Text]
  65. Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, Aronson D, Goodyear LJ, and Horton ES. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 48: 1192–1197, 1999.[Abstract]
  66. King PA, Hirshman MF, Horton ED, and Horton ES. Glucose transport in skeletal muscle membrane vesicles from control and exercised rats. Am J Physiol Cell Physiol 257: C1128–C1134, 1989.[Abstract/Free Full Text]
  67. Kingwell BA, Formosa M, Muhlmann M, Bradley SJ, and McConell GK. Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects. Diabetes 51: 2572–2580, 2002.[Abstract/Free Full Text]
  68. Klip A, Li G, and Logan WJ. Role of calcium ions in insulin action on hexose transport in L6 muscle cells. Am J Physiol Endocrinol Metab 247: E297–E304, 1984.[Abstract/Free Full Text]
  69. Kristiansen S, Gade J, Wojtaszewski JF, Kiens B, and Richter EA. Glucose uptake is increased in trained vs. untrained muscle during heavy exercise. J Appl Physiol 89: 1151–1158, 2000.[Abstract/Free Full Text]
  70. Kristiansen S, Hargreaves M, and Richter EA. Exercise-induced increase in glucose transport, GLUT-4, and VAMP-2 in plasma membrane from human muscle. Am J Physiol Endocrinol Metab 270: E197–E201, 1996.[Abstract/Free Full Text]
  71. Lebrasseur NK, Cote GM, Miller TA, Fielding RA, and Sawyer DB. Regulation of neuregulin/ErbB signaling by contractile activity in skeletal muscle. Am J Physiol Cell Physiol 284: C1149–C1155, 2003.[Abstract/Free Full Text]
  72. Lee AD, Gulve EA, Chen M, Schluter J, and Holloszy JO. Effects of Ca2+ ionophore ionomycin on insulin-stimulated and basal glucose transport in muscle. Am J Physiol Regul Integr Comp Physiol 268: R997–R1002, 1995.[Abstract/Free Full Text]
  73. Lee AD, Hansen PA, and Holloszy JO. Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett 361: 51–54, 1995.[CrossRef][ISI][Medline]
  74. Lemieux K, Han XX, Dombrowski L, Bonen A, and Marette A. The transferrin receptor defines two distinct contraction-responsive GLUT4 vesicle populations in skeletal muscle. Diabetes 49: 183–189, 2000.[Abstract]
  75. Lund S, Holman GD, Schmitz O, and Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 92: 5817–5821, 1995.[Abstract/Free Full Text]
  76. MacLean DA, Bangsbo J, and Saltin B. Muscle interstitial glucose and lactate levels during dynamic exercise in humans determined by microdialysis. J Appl Physiol 87: 1483–1490, 1999.[Abstract/Free Full Text]
  77. Mackie BG and Terjung RL. Blood flow to different skeletal muscle fiber types during contraction. Am J Physiol Heart Circ Physiol 245: H265–H275, 1983.[Abstract/Free Full Text]
  78. Markuns JF, Wojtaszewski JF, and Goodyear LJ. Insulin and exercise decrease glycogen synthase kinase-3 activity by different mechanisms in rat skeletal muscle. J Biol Chem 274: 24896–24900, 1999.[Abstract/Free Full Text]
  79. Martin IK, Katz A, and Wahren J. Splanchnic and muscle metabolism during exercise in NIDDM patients. Am J Physiol Endocrinol Metab 269: E583–E590, 1995.[Abstract/Free Full Text]
  80. Merrill GF, Kurth EJ, Hardie DG, and Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273: E1107–E1112, 1997.[Abstract/Free Full Text]
  81. Mu J, Barton ER, and Birnbaum MJ. Selective suppression of AMP-activated protein kinase in skeletal muscle: update on ‘lazy mice’. Biochem Soc Trans 31: 236–241, 2003.[ISI][Medline]
  82. Mu J, Brozinick JT Jr, Valladares O, Bucan M, and Birnbaum MJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7: 1085–1094, 2001.[CrossRef][ISI][Medline]
  83. Musi N, Fujii N, Hirshman MF, Ekberg I, Froberg S, Ljungqvist O, Thorell A, and Goodyear LJ. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 50: 921–927, 2001.[Abstract/Free Full Text]
  84. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, and Goodyear LJ. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51: 2074–2081, 2002.[Abstract/Free Full Text]
  85. Nesher R, Karl IE, and Kipnis DM. Dissociation of effects of insulin and contraction on glucose transport in rat epitrochlearis muscle. Am J Physiol Cell Physiol 249: C226–C232, 1985.[Abstract/Free Full Text]
  86. Nielsen JN, Frøsig C, Sajan MP, Miura A, Standaert ML, Graham DA, Wojtaszewski JF, Farese RV, and Richter EA. Increased atypical PKC activity in endurance-trained human skeletal muscle. Biochem Biophys Res Commun 312: 1147–1153, 2003.[CrossRef][ISI][Medline]
  87. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484–496, 1995.[Abstract]
  88. Pendergrass M, Koval J, Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, Ardehali H, Printz R, Granner D, DeFronzo RA, and Mandarino LJ. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. Diabetes 47: 387–394, 1998.[Abstract]
  89. Perrini S, Henriksson J, Zierath JR, and Widegren U. Exercise-induced protein kinase C isoform-specific activation in human skeletal muscle. Diabetes 53: 21–24, 2004.[Abstract/Free Full Text]
  90. Ploug T, Galbo H, Ohkuwa T, Tranum-Jensen J, and Vinten J. Kinetics of glucose transport in rat skeletal muscle membrane vesicles: effects of insulin and contractions. Am J Physiol Endocrinol Metab 262: E700–E711, 1992.[Abstract/Free Full Text]
  91. Ploug T, Galbo H, Vinten J, Jorgensen M, and Richter EA. Kinetics of glucose transport in rat muscle: effects of insulin and contractions. Am J Physiol Endocrinol Metab 253: E12–E20, 1987.[Abstract/Free Full Text]
  92. Ploug T, van Deurs B, Ai H, Cushman SW, and Ralston E. Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are recruited by insulin and muscle contractions. J Cell Biol 142: 1429–1446, 1998.[Abstract/Free Full Text]
  93. Ploug T and Ralston E. Anatomy of glucose transporters in skeletal muscle. Effects of insulin and contractions. Adv Exp Med Biol 441: 17–26, 1998.[Medline]
  94. Randhawa VK, Bilan PJ, Khayat ZA, Daneman N, Liu Z, Ramlal T, Volchuk A, Peng XR, Coppola T, Regazzi R, Trimble WS, and Klip A. VAMP2, but not VAMP3/cellubrevin, mediates insulin-dependent incorporation of GLUT4 into the plasma membrane of L6 myoblasts. Mol Biol Cell 11: 2403–2417, 2000.[Abstract/Free Full Text]
  95. Rattigan S, Wheatley C, Richards SM, Barrett EJ, and Clark MG. Exercise and insulin-mediated capillary recruitment in muscle. Exerc Sport Sci Rev 33: 43–48, 2005.[ISI][Medline]
  96. Ribe D, Yang J, Patel S, Koumanov F, Cushman SW, and Holman GD. Endofacial competitive inhibition of GLUT4 intrinsic activity by the MAP kinase inhibitor SB203580. Endocrinology (January 20, 2005); doi:10.1210/en.2004-1294.[Abstract/Free Full Text]
  97. Richter EA. Glucose utilization. In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. Bethesda, MD: 1996, sect. 12, chapt. 20, p. 913–951.
  98. Richter EA, Cleland PJ, Rattigan S, and Clark MG. Contraction-associated translocation of protein kinase C in rat skeletal muscle. FEBS Lett 217: 232–236, 1987.[CrossRef][ISI][Medline]
  99. Richter EA, Jensen P, Kiens B, and Kristiansen S. Sarcolemmal glucose transport and GLUT-4 translocation during exercise are diminished by endurance training. Am J Physiol Endocrinol Metab 274: E89–E95, 1998.[Abstract/Free Full Text]
  100. Richter EA, Vistisen B, Maarbjerg SJ, Sajan M, Farese RV, and Kiens B. Differential effect of bicycling exercise intensity on activity and phosphorylation of atypical protein kinase C and extracellular signal-regulated protein kinase in skeletal muscle. J Physiol 560: 909–918, 2004.[Abstract/Free Full Text]
  101. Roberts CK, Barnard RJ, Jasman A, and Balon TW. Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am J Physiol Endocrinol Metab 277: E390–E394, 1999.[Abstract/Free Full Text]
  102. Roberts CK, Barnard RJ, Scheck SH, and Balon TW. Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent. Am J Physiol Endocrinol Metab 273: E220–E225, 1997.[Abstract/Free Full Text]
  103. Roepstorff C, Halberg N, Hillig T, Saha AK, Ruderman NB, Wojtaszewski JF, Richter EA, and Kiens B. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am J Physiol Endocrinol Metab 288: E133–E142, 2005.[Abstract/Free Full Text]
  104. Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, and Wolfe RR. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol Endocrinol Metab 265: E380–E391, 1993.[Abstract/Free Full Text]
  105. Rose AJ and Hargreaves M. Exercise increases Ca2+-calmodulin-dependent protein kinase II activity in human skeletal muscle. J Physiol 553: 303–309, 2003.[Abstract/Free Full Text]
  106. Rose AJ, Michell BJ, Kemp BE, and Hargreaves M. Effect of exercise on protein kinase C activity and localization in human skeletal muscle. J Physiol 561: 861–870, 2004.[Abstract/Free Full Text]
  107. Rottman JN, Bracy D, Malabanan C, Yue Z, Clanton J, and Wasserman DH. Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. Am J Physiol Endocrinol Metab 283: E116–E123, 2002.[Abstract/Free Full Text]
  108. Roy D, Johannsson E, Bonen A, and Marette A. Electrical stimulation induces fiber type-specific translocation of GLUT-4 to T tubules in skeletal muscle. Am J Physiol Endocrinol Metab 273: E688–E694, 1997.[Abstract/Free Full Text]
  109. Roy D and Marette A. Exercise induces the translocation of GLUT4 to transverse tubules from an intracellular pool in rat skeletal muscle. Biochem Biophys Res Commun 223: 147–152, 1996.[CrossRef][ISI][Medline]
  110. Ryder JW, Kawano Y, Galuska D, Fahlman R, Wallberg-Henriksson H, Charron MJ, and Zierath JR. Postexercise glucose uptake and glycogen synthesis in skeletal muscle from GLUT4-deficient mice. FASEB J 13: 2246–2256, 1999.[Abstract/Free Full Text]
  111. Sakamoto K, Arnolds DE, Ekberg I, Thorell A, and Goodyear LJ. Exercise regulates Akt and glycogen synthase kinase-3 activities in human skeletal muscle. Biochem Biophys Res Commun 319: 419–425, 2004.[CrossRef][ISI][Medline]
  112. Sakamoto K, Aschenbach WG, Hirshman MF, and Goodyear LJ. Akt signaling in skeletal muscle: regulation by exercise and passive stretch. Am J Physiol Endocrinol Metab 285: E1081–E1088, 2003.[Abstract/Free Full Text]
  113. Sakamoto K and Goodyear LJ. Invited review: intracellular signaling in contracting skeletal muscle. J Appl Physiol 93: 369–383, 2002.[Abstract/Free Full Text]
  114. Sakamoto K, Hirshman MF, Aschenbach WG, and Goodyear LJ. Contraction regulation of Akt in rat skeletal muscle. J Biol Chem 277: 11910–11917, 2002.[Abstract/Free Full Text]
  115. Sakamoto K, Hishman MF, Fujii N, Arnolds D, Birnbaum MJ, and Goodyear LJ. Akt2 regulates insulin-stimulated, but not contraction-stimulated glycogen synthase activation in skeletal muscle (Abstract). Diabetes 52S: A62, 2004.
  116. Saltin B and Gollnick PD. Skeletal muscle adaptability: significance for metabolism and performance. In: Handbook of Physiology. Skeletal Muscle. Bethesda, MD: Am. Physiol. Soc., 1983, sect. 10, chapt. 19, p. 555–631.
  117. Sano H, Kane S, Sano E, Miinea CP, Asara JM, Lane WS, Garner CW, and Lienhard GE. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 278: 14599–14602, 2003.[Abstract/Free Full Text]
  118. Sherman LA, Hirshman MF, Cormont M, Le Marchand-Brustel Y, and Goodyear LJ. Differential effects of insulin and exercise on Rab4 distribution in rat skeletal muscle. Endocrinology 137: 266–273, 1996.